|
NewsPapers
- -04-18-07 Study: Chondroitin Not Very Effective for Joint Pain (ABC)
"The study, called a meta-analysis, combines data from 20 prior studies examining the benefits of chondroitin on knee or hip arthritis."
"What the analysis found was that chondroitin was only minimally beneficial, if at all, in treating joint pain from arthritis and should not be recommended as treatment." 04-07
Purchase Resources
- -Fight Arthritis with Broccoli (WorldHealth.net)
"Cruciferous vegetables – such as broccoli, Brussels sprouts, and cabbage – are a rich source of sulforaphane, a compound for which previous studies suggest an anti-inflammatory effect. Ian Clark, from the University of East Anglia (United Kingdom), and colleagues have shown that sulforaphane slows down the destruction of cartilage in joints associated with painful and often debilitating osteoarthritis."
- Arthritis (About.com - Eustice)
Provides core reference resources for arthritis. 3-01
- Arthritis (Healthopedia.com)
Provides detailed information, listed by condition. 8-04
- Arthritis - Drugs for Treatment (About.com - Eustice)
Describes the most common medications used with arthritis. 3-01
- Gout Treatment (U.S. News)
"Gout develops when too much uric acid accumulates in the blood, soft tissues, or joints. Uloric, made by Takeda Pharmaceutical, works by lowering these levels. Compounds called purines, which can increase levels of uric acid in the body, are abundant in beer, red meat, and seafood, including shellfish. That's why those foods should be avoided. Gout is a 'severe [form of] arthritis that . . . usually involves just a single joint,' says N. Lawrence Edwards, a professor of medicine at the University of Florida and CEO of the Chicago-based nonprofit group called the Gout and Uric Acid Education Society who has served as a consultant for Takeda and other drug companies." 3-09
- Vioxx Facts (ABC News)
"Pharmaceutical giant Merck & Co. pulled its anti-inflammatory drug Vioxx off the shelves today in a voluntary recall after a clinical trial found patients using the drug had an increased risk of heart attacks and strokes. The following are some facts on the once-popular medication."
"Vioxx is the name Merck & Co. gave to rofecoxib, a non-steroidal anti-inflammatory drug (NSAID) developed by the company in the 1990s."
"Vioxx is classified as a COX-2 inhibitor, a type of pain relief that works by inhibiting an enzyme (cyclooxygenase) involved in inflammation."
"In September 2004, the FDA approved Vioxx for juvenile rheumatoid arthritis, the first COX-2 inhibitor to be approved for JRA." 10-04
- Knee Joint Treatment (Synvisc.com)
"Generally, most people experience maximum pain relief 8-10 weeks after starting SYNVISC treatment. The full course of 3 injections is needed for maximum benefit." Awesome Library does not endorse this treatment but provides it as an example. 10-08
|